Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis
Status:
Completed
Trial end date:
2020-08-14
Target enrollment:
Participant gender:
Summary
This multicenter prospective clinical trial investigates the accuracy of ultrasound to
predict relapse after discontinuation of infliximab and the efficacy/safety of
readministration of infliximab in patients with rheumatoid arthritis in a low disease
activity state.